US 9562217
Modalities for the treatment of degenerative diseases of the retina
granted A61KA61K35/12A61K35/30
Quick answer
US patent 9562217 (Modalities for the treatment of degenerative diseases of the retina) held by Astellas Institute for Regenerative Medicine expires Mon Feb 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Astellas Institute for Regenerative Medicine
- Grant date
- Tue Feb 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K35/12, A61K35/30, A61K35/36, A61K35/44